About Theracrine

About company

Theracrine Inc. is a private biopharmaceutical company dedicated to the discovery and development of novel therapeutics in the emerging field of cancer spread. Theracrine's biology platform has produced multiple proprietary molecular targets and the company is rapidly developing therapeutics against the highest priority targets. Theracrine was founded in 2010 by life science investor Flagship Ventures and the scientific leaders in the biology of cancer spread.